V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 220007178 | 220002803 | 0 | 71 | Not known (9) | 2015-03-31 | 2015-04-03 | IDARUBICIN + TRETINOIN | Y | N | 220031857 | IDARUBICIN + TRETINOIN |
| 220007179 | 220002804 | 0 | 87.7 | Curative (C) | 2017-01-15 | 2017-01-25 | AML 18 Pilot Trial | N | N | 220031869 | PILOT TRIAL |
| 220007180 | 220002804 | 1.52 | null | Palliative (P) | 2015-03-18 | 2015-03-23 | Dasatinib | 02 | N | 220031869 | DASATINIB |
| 220007181 | 220002804 | 1.63 | 76 | Curative (C) | 2015-08-25 | 2015-09-07 | AML16 DA 2+5 | N | N | 220031869 | AML16 TRIAL |
| 220007182 | 220002804 | 1.81 | 89.9 | Palliative (P) | 2014-04-19 | 2014-04-30 | Dasatinib | 2 | N | 220031869 | DASATINIB |
| 220007183 | 220002805 | 1.76 | null | Palliative (P) | 2017-02-09 | 2017-02-09 | IDARUBICIN + TRETINOIN | N | N | 220031880 | IDARUBICIN + TRETINOIN |
| 220007185 | 220002807 | 1.79 | null | Curative (C) | 2014-08-31 | 2014-09-08 | AML16 DA 3+10 | N | N | 220031885 | AML16 TRIAL |
| 220007186 | 220002807 | 1.68 | null | Curative (C) | null | 2017-01-18 | AML 18 TRIAL | 01 | N | 220031885 | AML18 TRIAL |
| 220007187 | 220002807 | 1.82 | 79 | Palliative (P) | 2015-02-07 | 2015-02-27 | Carboplatin + Paclitaxel (3 weekly) | 2 | N | 220031885 | CARBOPLATIN + PACLITAXEL |
| 220007188 | 220002807 | 1.82 | null | Palliative (P) | 2016-11-15 | 2016-11-29 | CARBOPLATIN + GEMCITABINE | N | null | 220031885 | GEMCARBO |
| 220007189 | 220020408 | 1.75 | null | Curative (C) | 2013-06-21 | 2013-06-29 | AML18 PILOT TRIAL | 1 | N | 220031893 | PILOT TRIAL |
| 220007193 | 220002808 | 1.63 | null | Palliative (P) | 2016-10-13 | 2016-11-04 | Carboplatin + Paclitaxel (3 weekly) | 02 | N | 220031898 | CARBOPLATIN + PACLITAXEL |
| 220007194 | 220002809 | 1.79 | 133.4 | null | 2015-02-14 | 2015-02-14 | AML16 Low Dose Cytarabine | N | N | 220031899 | AML16 TRIAL |
| 220007195 | 220002809 | 1.56 | null | Curative (C) | null | 2015-06-08 | AML18 PILOT TRIAL | Y | N | 220031899 | PILOT TRIAL |
| 220007196 | 220002809 | null | 76 | null | 2014-11-26 | 2014-11-26 | CISPLATIN + GEMCITABINE | 02 | N | 220031899 | CISPLATIN + GEMCITABINE |
| 220007197 | 220002809 | 1.68 | 59.8 | null | null | 2016-09-06 | AML16 Low Dose Cytarabine | N | N | 220031899 | AML16 TRIAL |
| 220007198 | 220002810 | 1.83 | 75.6 | Palliative (P) | 2014-11-21 | 2014-11-21 | Cisplatin + Gemcitabine (D 1 & 8) | N | null | 220031908 | CISPLATIN + GEMCITABINE |
| 220007199 | 220002811 | 1.6 | 50 | Palliative (P) | null | 2013-05-10 | Carboplatin + Paclitaxel (3 weekly) | N | N | 220031909 | CARBOPLATIN + PACLITAXEL |
| 220007200 | 220002812 | 0 | null | Palliative (P) | 2016-05-20 | 2016-06-24 | Carboplatin + Paclitaxel (3 weekly) | 2 | N | 220031910 | CARBOPLATIN + PACLITAXEL |
| 220007201 | 220002812 | 1.67 | 86.3 | Disease modification (D) | 2016-06-06 | 2016-06-06 | Dasatinib | 2 | null | 220031910 | DASATINIB |
| 220007202 | 220002813 | 1.67 | 82.1 | Palliative (P) | 2017-01-13 | 2017-04-29 | GemCarbo Days 1+8 | N | N | 220031912 | GEMCARBO |
| 220007203 | 220002814 | null | 85.2 | Curative (C) | 2014-02-19 | 2014-03-05 | AML 18 TRIAL | Y | N | 220031916 | AML18 TRIAL |
| 220007204 | 220011602 | 1.6 | 79 | Palliative (P) | 2014-07-06 | 2014-07-06 | GemCarbo Days 1+8 | N | N | 220031919 | GEMCARBO |
| 220007205 | 220002815 | 1.52 | null | Palliative (P) | 2015-02-04 | 2015-02-05 | GEMCARBO | 02 | N | 220031920 | GEMCARBO |
| 220007206 | 220002815 | 1.7 | 83.3 | Palliative (P) | null | 2016-07-18 | Carboplatin + Paclitaxel (3 weekly) | N | N | 220031920 | CARBOPLATIN + PACLITAXEL |
| 220007207 | 220002816 | 1.55 | 53 | null | 2014-11-13 | 2014-11-18 | GemCarbo Days 1+8 | N | N | 220031922 | GEMCARBO |
| 220007208 | 220002816 | 1.87 | 128 | Curative (C) | null | 2014-08-09 | Carboplatin + Paclitaxel (3 weekly) | N | null | 220031922 | CARBOPLATIN + PACLITAXEL |
| 220007209 | 220016243 | 1.67 | 80.9 | Curative (C) | 2013-08-08 | 2013-08-08 | Idarubicin+Tretinoin Spanish Crse1 | 02 | N | 220031924 | IDARUBICIN + TRETINOIN |
| 220007210 | 220002817 | 1.82 | null | Palliative (P) | 2013-12-23 | 2013-12-28 | GemCarbo Days 1+8 | null | N | 220031925 | GEMCARBO |
| 220007211 | 220011605 | 1.54 | null | Palliative (P) | 2016-10-04 | 2017-11-08 | Dasatinib | 2 | N | 220031929 | DASATINIB |
| 220007212 | 220011605 | null | 125 | Curative (C) | 2017-01-08 | 2017-01-11 | AML18 PILOT TRIAL | N | N | 220031929 | PILOT TRIAL |
| 220007213 | 220011605 | 1.77 | 89.6 | Curative (C) | 2016-03-19 | 2016-03-19 | AML18 PILOT TRIAL | Y | N | 220031929 | PILOT TRIAL |
| 220007214 | 220011605 | 1.6 | 87.5 | Curative (C) | 2017-03-04 | 2017-03-05 | AML 18 TRIAL | 01 | N | 220031929 | AML18 TRIAL |
| 220007215 | 220011605 | 1.65 | 97.5 | null | 2016-10-03 | 2016-10-03 | CISPLATIN + GEMCITABINE | 02 | N | 220031929 | CISPLATIN + GEMCITABINE |
| 220007218 | 220002819 | 1.64 | 63.4 | Curative (C) | 2018-07-17 | 2018-07-17 | Dasatinib | N | N | 220031943 | DASATINIB |
| 220007219 | 220002819 | 1.59 | 45.8 | null | 2014-04-29 | 2014-04-30 | Dasatinib | 2 | N | 220031943 | DASATINIB |
| 220007221 | 220002821 | 1.69 | 96.4 | Disease modification (D) | 2017-01-14 | 2017-01-21 | AML16 DA 3+10 | N | N | 220031947 | AML16 TRIAL |
| 220007222 | 220011607 | 1.77 | 90 | Curative (C) | 2014-08-01 | 2014-08-02 | IDARUBICIN + TRETINOIN | 2 | N | 220031948 | IDARUBICIN + TRETINOIN |
| 220007223 | 220002822 | 1.6 | 87 | Palliative (P) | 2017-11-28 | 2018-01-02 | Carboplatin + Paclitaxel (3 weekly) | N | N | 220031949 | CARBOPLATIN + PACLITAXEL |
| 220007224 | 220002823 | 1.71 | 95 | Curative (C) | 2014-10-18 | 2014-10-22 | IDARUBICIN + TRETINOIN | 02 | N | 220031952 | IDARUBICIN + TRETINOIN |
| 220007225 | 220002824 | 1.86 | 71 | Curative (C) | 2014-12-02 | 2014-12-02 | Idarubicin+Tretinoin Spanish Crse1 | null | N | 220031953 | IDARUBICIN + TRETINOIN |
| 220007226 | 220002825 | 1.64 | 47.5 | Palliative (P) | 2016-01-26 | 2016-02-08 | CARBOPLATIN + PACLITAXEL | N | N | 220031957 | CARBOPLATIN + PACLITAXEL |
| 220007228 | 220002826 | 1.84 | null | Palliative (P) | 2016-02-04 | 2016-02-04 | Dasatinib | N | N | 220031961 | DASATINIB |
| 220007229 | 220002826 | 0 | 62.2 | Curative (C) | null | 2013-06-22 | AML18 PILOT TRIAL | Y | N | 220031961 | PILOT TRIAL |
| 220007230 | 220002826 | 0 | 99.6 | Palliative (P) | 2014-05-31 | 2014-06-05 | GEMCARBO | N | N | 220031961 | GEMCARBO |
| 220007231 | 220002827 | 1.76 | 80 | Curative (C) | 2014-10-06 | 2014-10-06 | AML16 Low Dose Cytarabine | N | null | 220031967 | AML16 TRIAL |
| 220007232 | 220002827 | 0 | 0 | Neo-adjuvant (N) | 2013-01-25 | 2013-02-17 | CARBOPLATIN + PACLITAXEL | 02 | N | 220031967 | CARBOPLATIN + PACLITAXEL |
| 220007233 | 220002827 | 1.7 | 79.5 | Curative (C) | null | 2015-06-15 | Idarubicin+Tretinoin Spanish Crse1 | N | N | 220031967 | IDARUBICIN + TRETINOIN |
| 220007234 | 220018890 | 1.82 | 93.1 | Curative (C) | 2014-02-18 | 2014-02-23 | AML 18 TRIAL | 01 | N | 220031971 | AML18 TRIAL |
| 220007235 | 220018890 | null | 67 | Curative (C) | 2017-06-13 | 2017-06-13 | IDARUBICIN + TRETINOIN | Y | N | 220031971 | IDARUBICIN + TRETINOIN |